Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant -- or because he's an ineffective leader?
China will spend billions on biotech, even as the industry struggles in the U.S. to turn research into gold. Will U.S. biotech become the next Detroit?
A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.
India's Ranbaxy won the right to make a generic version of the $11 billion drug -- only to be accused of seri ous fraud and shoddy practices in another case. Now a fight is erupting over the mega-popular cholesterol medication.
Money magazine's Best Deals on Everything: Your guide to the latest bargains in used, new and leased cars.
Startup ideas can be found in surprising places. We asked Thumbtack.com which opportunities are drawing the most interest from entrepreneurs and their customers lately.
The all-new full-sized Chevrolet looks and performs beyond its mass-market league.
Money magazine's Best Deals on Everything: Your guide to the latest bargains in renting, buying or remodeling your home.
Microsoft is making a bid to own the living room with its new entertainment device.
As well as the 5 best.
Retiring boomers are helping the recreational vehicle industry get back on track. Here are 8 choices for traveling in style.
Money magazine's Best Deals on Everything: Your guide to the latest bargains in the investing world, from beer can makers and ETFs, to Chinese technology and more.
From a restaurant owner who hid cash receipts in "seasoned octopus" boxes to a self-proclaimed governor of Alabama who buried gold coins in his yard, here are some of ...
.
